Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial
Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial
نویسندگان: عطا محمودپور , هادی همیشه کار , سروین سنایی اسکویی , رقیه اصغری , رامین ابری , کامران شادور
کلمات کلیدی: Keywords
critical illness; intensive care unit; probiotics; ventilator-associated pneumonia
نشریه: 25850 , 1 , 34 , 2019
| نویسنده ثبت کننده مقاله |
هادی همیشه کار |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده داروسازی |
| کد مقاله |
70936 |
| عنوان فارسی مقاله |
Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial |
| عنوان لاتین مقاله |
Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial |
| ناشر |
6 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: Ventilator-associated pneumonia (VAP) occurs as a life-threatening complication in critically ill mechanically
ventilated patients. Probiotic administration may modify the gut microbiota; however, whether this modification could decrease
VAP occurrence is not known. Methods: In this study, 100 adult critically ill patients undergoing mechanical ventilation for >48
hours were randomly assigned to either the probiotic or the control group. The patients in the probiotic group received 2 capsules
of probiotic preparation containing Lactobacillus, Bifidobacterium, and Streptococcus spp., and those in the control group received
placebo daily for 14 days. Results: The patients in the probiotic group had a lower incidence of statistically microbiologically
confirmed VAP. The duration of intensive care unit (ICU) and hospital stay was also lower in the probiotic group (P < .05).More
than half of the patients in the control group had gastric residuals during ICU stay, compared with only 30% of patients in the
probiotic group (P = .004). Probiotic usage led to a nonsignificant decrease in diarrhea, gastric and oropharyngeal colonization,
and incidence of multidrug-resistant pathogens. TheKaplan-Meier survival curves for time to the first episode of VAP did not show
a significant difference between probiotic and control groups (log-rank test = 1.89; P = .17). Conclusions: The results of probiotic
administration for the prevention of VAP remain inconclusive in this trial. However, such an approach can decrease the length of
ICU and hospital stay. Well-designed multicenter clinical studies with defined combinations of probiotics and definite end points
are necessary in this field. (Nutr Clin Pract. 2019;34:156–162) |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Effect of a Probiotic Preparation on Ventilator.pdf | 1398/11/08 | 690655 | دانلود |